Article Information
vol. 6 no. 42
- Received for publication March 2, 2020
- Accepted for publication September 1, 2020
- .
Author Information
- Jia Li1,
- Sibo Zhao2,3,
- Minjung Lee1,
- Yue Yin1,
- Jin Li1,
- Yubin Zhou4,
- Leomar Y. Ballester5,6,
- Yoshua Esquenazi6,
- Roderick H. Dashwood1,
- Peter J. A. Davies4,
- D. Williams Parsons2,
- Xiao-Nan Li2,7,*,
- Yun Huang1,* and
- Deqiang Sun1,8,9,*
- 1Center for Epigenetics and Disease Prevention, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA.
- 2Texas Children’s Hospital, Baylor College of Medicine, Houston, TX 77030, USA.
- 3Department of Hematology and Oncology, Cook Children’s Medical Center, Fort Worth, TX 76104, USA.
- 4Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA.
- 5Department of Pathology and Laboratory Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
- 6Department of Neurosurgery, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
- 7Program of Precision Medicine PDOX Modeling of Pediatric Cancers, Department of Pediatrics, Ann & Robert H. Lurie Children’s Hospital of Chicago, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
- 8Gomics Technology Corporation, 7707 Fannin Street, Suite 200, Houston, TX 77054, USA.
- 9Department of Cardiology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.
- ↵*Corresponding author. Email: xli{at}luriechildrens.org (X.-N.L.); yun.huang{at}tamu.edu (Y.H.); dsun{at}gomicstech.com (D.S.)